3.1(top 5%)
Impact Factor
3.5(top 5%)
extended IF
101(top 3%)
citing journals
citing authors

Most Cited Articles of Therapeutic Drug Monitoring in 2008

Infliximab pharmacokinetics in inflammatory bowel disease patients2008143
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations2008123
Determination of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in hair: a promising way for retrospective detection of alcohol abuse during pregnancy?2008122
Therapeutic drug monitoring of voriconazole2008107
Suboptimal aminoglycoside dosing in critically ill patients2008107
CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response2008104
An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients200899
Determination of morphine and 6-acetylmorphine in blood with use of dried blood spots200892
Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring200887
Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults200885
High-speed simultaneous determination of nine antiepileptic drugs using liquid chromatography-mass spectrometry200878
Acute chlorophenylpiperazine overdose: a case report and review of the literature200875
Screening for basic drugs in hair of drug addicts by liquid chromatography/time-of-flight mass spectrometry200872
Population pharmacokinetics of intravenous, intramuscular, and intranasal naloxone in human volunteers200870
Glutathione S-transferase polymorphisms are not associated with population pharmacokinetic parameters of busulfan in pediatric patients200867
Influence of drug transporters and UGT polymorphisms on pharmacokinetics of phenolic glucuronide metabolite of mycophenolic acid in Japanese renal transplant recipients200865
Alarming prevalence of fetal alcohol exposure in a Mediterranean city200864
The relationship between the response of clinical symptoms and plasma olanzapine concentration, based on pharmacogenetics: Juntendo University Schizophrenia Projects (JUSP)200860
CYP3A7, CYP3A5, CYP3A4, and ABCB1 genetic polymorphisms, cyclosporine concentration, and dose requirement in transplant recipients200857
Current developments in drug testing in oral fluid200852
Prevalence of fetal ethanol exposure in a regional population-based sample by meconium analysis of fatty acid ethyl esters200851
Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs200851
First clinical experience with the new once-daily formulation of tacrolimus200850
ABCB1 polymorphisms influence steady-state plasma levels of 9-hydroxyrisperidone and risperidone active moiety200850
Influence of lansoprazole and rabeprazole on mycophenolic acid pharmacokinetics one year after renal transplantation200847